Profil
Pär Martin Ericson is currently the Chief Executive Officer at Gylling Invest AB since 2011.
He previously worked as the Chairman at Iterata AB and as the Chief Financial Officer & Vice President-Finance at Hapron Technology AB from 2009 to 2013.
Aktive Positionen von Pär Martin Ericson
| Unternehmen | Position | Beginn |
|---|---|---|
Gylling Invest AB
Gylling Invest AB Investment ManagersFinance Gylling Invest is an active, long-term manager which primarily invests in early-stage technology companies which are planning their initial market entry or expanding their initial market. They focus mainly on unlisted Scandinavian businesses but also consider listed companies. The firm seeks to create value and secure return on investments by investing an initial SEK 2-10 million and a total investment of up to SEK 20 million in developing companies. They partner with their investee companies, seeking board representation and contributing their business development and international commercialization expertise. | Vorstandsvorsitzender | 04.10.2011 |
Ehemalige bekannte Positionen von Pär Martin Ericson
| Unternehmen | Position | Ende |
|---|---|---|
Iterata AB
Iterata AB BiotechnologyHealth Technology Develops biotechnology | Vorsitzender | - |
Hapron Technology AB
Hapron Technology AB Wholesale DistributorsDistribution Services Designs and manufactures ergonomically optimized tools and devices for computerized work places | Finanzdirektor/CFO | 12.11.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Gylling Invest AB
Gylling Invest AB Investment ManagersFinance Gylling Invest is an active, long-term manager which primarily invests in early-stage technology companies which are planning their initial market entry or expanding their initial market. They focus mainly on unlisted Scandinavian businesses but also consider listed companies. The firm seeks to create value and secure return on investments by investing an initial SEK 2-10 million and a total investment of up to SEK 20 million in developing companies. They partner with their investee companies, seeking board representation and contributing their business development and international commercialization expertise. | Finance |
Iterata AB
Iterata AB BiotechnologyHealth Technology Develops biotechnology | Health Technology |
Hapron Technology AB
Hapron Technology AB Wholesale DistributorsDistribution Services Designs and manufactures ergonomically optimized tools and devices for computerized work places | Distribution Services |
















